Evelo Biosciences Inc (EVLO)
US$ 9.846.67%
Price Chart
Key Statistics
Market Cap
$ 9.49K
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
103.91K
52W High
$ 0.06
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
0.76
Technicals
50-Day MA
0.0005
200-Day MA
0.0005
52 Week High
0.06
52 Week Low
0.0001
About EVLO
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects.
Employees
66
Headquarters
Cambridge, MA
CEO
Mr. Craig R. Jalbert CIRA
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg